multi omics data (Foundation Medicine Inc)
Foundation Medicine Inc is a verified supplier 
Foundation Medicine Inc manufactures this product 
99
Structured Review
Foundation Medicine Inc
multi omics data
Multi Omics Data, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 99/100, based on 2328 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+omics+data/FoundationOne+CDx/pm42034603-270-30-37
Average 99 stars, based on 2328 article reviews
Multi Omics Data, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 99/100, based on 2328 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi+omics+data/FoundationOne+CDx/pm42034603-270-30-37
Average 99 stars, based on 2328 article reviews
multi omics data - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Diagnostic Assay:Article Title: Impact of BRCA Alterations on Androgen Receptor Pathway Inhibition Treatment Outcomes in Advanced Prostate Cancer Article Snippet: .. Diagnostic tissue samples from LATITUDE were tested using Tissue:Article Title: Impact of BRCA Alterations on Androgen Receptor Pathway Inhibition Treatment Outcomes in Advanced Prostate Cancer Article Snippet: .. Diagnostic tissue samples from LATITUDE were tested using Article Title: Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial. Article Snippet: .. Biomarker testing and classification Both tumour tissue (mostly archival) and Biomarker Discovery:Article Title: Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial. Article Snippet: .. Biomarker testing and classification Both tumour tissue (mostly archival) and Blood/Plasma/Serum Samples:Article Title: Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial. Article Snippet: .. Biomarker testing and classification Both tumour tissue (mostly archival) and Analysis:Article Title: Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial. Article Snippet: .. Biomarker testing and classification Both tumour tissue (mostly archival) and Derivative Assay:Article Title: Determining the Causal Effect of Neurotrophic Tropomyosin Receptor Kinase Gene Fusions on Survival Prognosis for Adult Patients With Advanced Cancers Article Snippet: .. Patient records were linked to the Flatiron Health-Foundation Medicine Clinico-Genomic Database, with all patient genomic data derived from Foundation Medicine comprehensive genomic profiling tests (ie, Profiling:Article Title: Determining the Causal Effect of Neurotrophic Tropomyosin Receptor Kinase Gene Fusions on Survival Prognosis for Adult Patients With Advanced Cancers Article Snippet: .. Patient records were linked to the Flatiron Health-Foundation Medicine Clinico-Genomic Database, with all patient genomic data derived from Foundation Medicine comprehensive genomic profiling tests (ie, |